These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 28328081)

  • 1. BTK inhibition is a potent approach to block IgE-mediated histamine release in human basophils.
    Smiljkovic D; Blatt K; Stefanzl G; Dorofeeva Y; Skrabs C; Focke-Tejkl M; Sperr WR; Jaeger U; Valenta R; Valent P
    Allergy; 2017 Nov; 72(11):1666-1676. PubMed ID: 28328081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils.
    Kneidinger M; Schmidt U; Rix U; Gleixner KV; Vales A; Baumgartner C; Lupinek C; Weghofer M; Bennett KL; Herrmann H; Schebesta A; Thomas WR; Vrtala S; Valenta R; Lee FY; Ellmeier W; Superti-Furga G; Valent P
    Blood; 2008 Mar; 111(6):3097-107. PubMed ID: 18180381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of IgE-mediated secretion from human basophils with a highly selective Bruton's tyrosine kinase, Btk, inhibitor.
    MacGlashan D; Honigberg LA; Smith A; Buggy J; Schroeder JT
    Int Immunopharmacol; 2011 Apr; 11(4):475-9. PubMed ID: 21238622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticosteroids rescue basophils from dasatinib-augmented immunoglobulin E-mediated histamine release.
    Herrmann H; Blatt K; Ghanim V; Kneidinger M; Marth K; Valenta R; Valent P
    Int Arch Allergy Immunol; 2012; 159(1):15-22. PubMed ID: 22555087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells.
    Gamperl S; Stefanzl G; Peter B; Smiljkovic D; Bauer K; Willmann M; Valent P; Hadzijusufovic E
    Vet Comp Oncol; 2019 Dec; 17(4):553-561. PubMed ID: 31286638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of basophil histamine release by tyrosine kinase and phosphatidylinositol 3-kinase inhibitors.
    Tedeschi A; Lorini M; Galbiati S; Gibelli S; Miadonna A
    Int J Immunopharmacol; 2000 Oct; 22(10):797-808. PubMed ID: 10963852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of tyrosine kinases in IgE-mediated signal transduction in human lung mast cells and basophils.
    Lavens SE; Peachell PT; Warner JA
    Am J Respir Cell Mol Biol; 1992 Dec; 7(6):637-44. PubMed ID: 1280450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of R59022, an inhibitor of diacylglycerol kinase, on IgE-mediated histamine release from human lung mast cells and basophils.
    O'Keefe KL; Warner JA
    Agents Actions; 1994 Nov; 43(1-2):1-6. PubMed ID: 7537937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PI3-kinase/mTOR-targeting drug NVP-BEZ235 inhibits growth and IgE-dependent activation of human mast cells and basophils.
    Blatt K; Herrmann H; Mirkina I; Hadzijusufovic E; Peter B; Strommer S; Hoermann G; Mayerhofer M; Hoetzenecker K; Klepetko W; Ghanim V; Marth K; Füreder T; Wacheck V; Valenta R; Valent P
    PLoS One; 2012; 7(1):e29925. PubMed ID: 22299028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midostaurin (PKC412) inhibits immunoglobulin E-dependent activation and mediator release in human blood basophils and mast cells.
    Krauth MT; Mirkina I; Herrmann H; Baumgartner C; Kneidinger M; Valent P
    Clin Exp Allergy; 2009 Nov; 39(11):1711-20. PubMed ID: 19860818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of bacterial lipopolysaccharide (LPS) on histamine release from human basophils. I. Enhancement of immunologic release by LPS.
    Smith TF; Aelvoet M; Morrison DC
    Clin Immunol Immunopathol; 1985 Mar; 34(3):355-65. PubMed ID: 2578909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applying surface plasmon resonance to monitor the IgE-mediated activation of human basophils.
    Suzuki H; Yanase Y; Tsutsui T; Ishii K; Hiragun T; Hide M
    Allergol Int; 2008 Dec; 57(4):347-58. PubMed ID: 18797180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of integrin clustering on human lung mast cells and basophils.
    Lavens SE; Goldring K; Thomas LH; Warner JA
    Am J Respir Cell Mol Biol; 1996 Jan; 14(1):95-103. PubMed ID: 8534491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human recombinant histamine releasing factor: functional evidence that it does not bind to the IgE molecule.
    Wantke F; MacGlashan DW; Langdon JM; MacDonald SM
    J Allergy Clin Immunol; 1999 Apr; 103(4):642-8. PubMed ID: 10200014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piceatannol is an effective inhibitor of IgE-mediated secretion from human basophils but is neither selective for this receptor nor acts on syk kinase at concentrations where mediator release inhibition occurs.
    Miura K; Lavens-Phillips S; MacGlashan DW
    Clin Exp Allergy; 2001 Nov; 31(11):1732-9. PubMed ID: 11696049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of tyrosine kinase inhibitors on IgE-mediated histamine release from human lung mast cells and basophils.
    Lavens-Phillips SE; Mockford EH; Warner JA
    Inflamm Res; 1998 Mar; 47(3):137-43. PubMed ID: 9562339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological concentrations of zinc inhibit the release of histamine from human basophils and lung mast cells.
    Marone G; Columbo M; de Paulis A; Cirillo R; Giugliano R; Condorelli M
    Agents Actions; 1986 Apr; 18(1-2):103-6. PubMed ID: 2425567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
    Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
    J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergen-specific conventional immunotherapy decreases immunoglobulin E-mediated basophil histamine releasability.
    Shim JY; Kim BS; Cho SH; Min KU; Hong SJ
    Clin Exp Allergy; 2003 Jan; 33(1):52-7. PubMed ID: 12534549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lidocaine on histamine release and Ca2+ mobilization from mast cells and basophils.
    Yanagi H; Sankawa H; Saito H; Iikura Y
    Acta Anaesthesiol Scand; 1996 Oct; 40(9):1138-44. PubMed ID: 8933856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.